Regulators of G protein signaling (Rgs) have pivotal roles in controlling various cellular processes, such as cell differentiation. How Rgs proteins regulate osteoclast (OC) differentiation, function and bone homeostasis is poorly understood. It was previously demonstrated that Rgs12, the largest protein in the Rgs family, is predominantly expressed in OCs and regulates OC differentiation in vitro. To further understand the role and mechanism of Rgs12 in OC differentiation and bone diseases in vivo, we created OC-targeted Rgs12 knockout mice by using inducible Mx1-Cre and CD11b-Cre. Deletion of Rgs12 in hematopoietic cells or specifically in OC precursors resulted in increased bone mass with decreased OC numbers. Loss of Rgs12 impaired OC differentiation and function with impaired Ca 2+ oscillations and reduced nuclear factor of activated T cells (NFAT) 2 expression. The introduction of wild-type osteoblasts did not rescue the defective osteoclastogenesis. Ectopic expression of NFAT2 rescued defective OC differentiation in CD11b;Rgs12 fl/fl cells and promoted normal OC differentiation. Moreover, deletion of Rgs12 significantly inhibited pathological osteoclastogenesis and bone destruction in Rgs12-deficient mice that were subjected to ovariectomy and lipodysaccharide for bone loss. Thus our findings demonstrate that Rgs12 is an important regulator in OC differentiation and function and identify Rgs12 as a potential therapeutic target for osteoporosis and inflammation-induced bone loss.
Bone homeostasis is tightly regulated by the balance between osteoblasts (OBs), the bone-forming cells, and osteoclasts (OCs), the bone-resorbing cells. 1 Pathological conditions such as osteoporosis, inflammation, and cancer break this balance in favor of the augmentation of OC activity, resulting in net bone loss. [2] [3] [4] As a result, patients with these diseases suffer from pain and risk of bone fracture. Therefore, understanding OC differentiation and function and uncovering potential therapeutic targets are very important and urgent objectives for treatment of these diseases. 5, 6 Mature OCs, derived from the monocyte/macrophage hematopoietic lineage, are multinucleated and tartrateresistant acid phosphatase (TRAP) positive. 7 The breakthrough in understanding osteoclastogenesis came from the discovery that receptor activator of NF-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) have essential roles in stimulating monocyte-macrophage lineage cells to differentiate into mature and functional OCs. [8] [9] [10] Currently, known crucial RANKL downstream transcription factors and genes include active nuclear factor of activated T cells (NFAT) 2, c-Fos, β 3 -integrin, Cathepsin K, and matrix metallopeptidase 9.
11,12 Among these, NFAT2 acts as a master switch for the terminal differentiation of OCs. 13 Robust induction of NFAT2 is dependent on calcium (Ca 2+ ) oscillations. 14 Ca
2+
oscillations lead to calcineurin-mediated activation of NFAT2 and ensure NFAT2 long-lasting transcriptional activation. 13, 14 Despite these new insights, it remains unclear which factor(s) induced by RANKL initiate and maintain Ca 2+ oscillations and how Ca 2+ oscillations regulate OC differentiation. Rgs12 is the largest protein in the Rgs (regulators of G-protein signaling) family. 15 Rgs12 has a PDZ (PSD-95/Dlg/ ZO-1) domain, a phosphotyrosine-binding domain, a conserved RGS domain, tandem Ras-binding domains, and a GoLoco interaction motif. [15] [16] [17] Its multi-domain structure allows Rgs12 to function as a signaling transduction nexus to modulate multiple signaling pathways. [17] [18] [19] [20] It was previously shown that, in vitro, Rgs12 expression gradually increases during OC differentiation and that silencing Rgs12 blocks OC differentiation, which suggests that Rgs12 is an important regulator of OC differentiation. 21 However, how Rgs12 regulates Ca 2+ oscillations and OC differentiation during bone development and remodeling in vivo is unknown. For this study, we created two strains of OC-targeted Rgs12 knockout mice -CD11b;Rgs12 fl/fl and Mx1;Rgs12 fl/fl mice. This was done by crossing Rgs12 fl/fl mice with either CD11b-Cre or Mx1-Cre transgenic mice, respectively. CD11b-Cre mice express Cre recombinase during myeloid differentiation under the control of the CD11b promoter. This strain is a useful tool for the study of gene function during OC and macrophage differentiation from embryonic stage. 22 Mx1-Cre mice express Cre recombinase in hematopoietic lineage cells, including early stage OC progenitor cells, and is induced by polyinosinic-polycytidylic acid (poly I:C). 23, 24 This strain makes it possible to study gene function at various postnatal bone development and remodeling stages.
We first studied the function of Rgs12 in hematopoietic cells, specifically in OC precursors, in vivo. We further analyzed how loss of Rgs12 affects the RANKL-Ca 2+ oscillations-NFAT2 signaling pathway. In addition to the physiological condition, we analyzed the role of Rgs12 in various pathological conditions to validate Rgs12 as a potential therapeutic target. We treated CD11b;Rgs12 fl/fl mice with lipodysaccharide (LPS) in the calvarial bone in order to mimic inflammation-induced osteoclastogenesis and bone destruction. We also studied the function of Rgs12 in estrogen deficiency-induced osteoporosis using an ovariectomy (OVX) model. Our results demonstrated that Rgs12 is an important regulator in OC differentiation and function and that Rgs12 is a potential therapeutic target for osteoporosis and inflammation-induced bone loss. fl/fl mice, Rgs12 was deleted in hematopoietic cells, including OCs, by injecting poly I:C at postnatal days 10, 12, and 14. In CD11b;Rgs12 fl/fl mice, Rgs12 was deleted in the monocyte-OC lineage at embryonic day E10.5. Both CD11b;Rgs12 fl/fl and Mx1;Rgs12 fl/fl mice were born with the expected Mendelian ratios. Deletion of Rgs12 was examined using spleen genomic DNA (Figures 1a  and d ). Low levels of Rgs12 mRNA in the spleen (Figure 1b ) and significantly diminished Rgs12 protein levels in the bone marrow ( Figure 1c ) were found in Mx1;Rgs12 fl/fl mice. CD11b-Cre deletion resulted in partial Rgs12 deletion in the spleen DNA (Figure 1d ), as expected. However, markedly lower Rgs12 mRNA and protein levels were found in the CD11b-positive cells derived from the bone marrow cells of CD11b;Rgs12 fl/fl mice (Figures 1e and f) . The function of Rgs12 in bone homeostasis X Yuan et al thickness (Tb.Th) in the femurs of Mx1;Rgs12 fl/fl mice were 2, 1.6, and 1.9-fold of those in control mice, respectively, while trabecular spacing (Tb.Sp) in the femurs of Mx1;Rgs12 fl/fl mice was 0.6-fold of that in control mice (Figure 2b , Po0.001). To further evaluate bone morphology, histological H&E staining analysis of the tibias from Mx1;Rgs12 fl/fl and Mx1;Rgs12 +/+ mice was performed (Figure 2c ). Compared with the control mouse tibia, Mx1;Rgs12 fl/fl mouse tibia exhibited a significant increase in the trabecular bone and cortical bone. Quantitative analysis confirmed that bone area in Mx1;Rgs12 fl/fl mice was 1.5-fold of that in controls (Figure 2d , Po0.001). To visualize OCs, the tibia histological sections were stained for TRAP activity. The OC number in Mx1;Rgs12 fl/fl tibia was 0.28-fold of that in control mice (Figures 2e and f Figure S1) . The results showed that there were not significant differences in bone formation between newborn CD11b;Rgs12 fl/+ and newborn CD11b;Rgs12 fl/fl mice, which suggests that Rgs12 does not significantly affect bone development in the embryonic stage. ). OCs can be generated in vitro from bone marrow-derived OC precursors when co-cultured with OB cells in the presence of 1α, 25-dihydroxyvitamin D 3 and dexamethasone. 26 These activated OBs can provide M-CSF and RANKL to support OC formation. 27 Thus we investigated whether co-culture of CD11b;Rgs12 fl/fl bone marrow cells with wild-type primary OBs was able to rescue the defective osteoclastogenesis. that the introduction of wild-type OBs did not rescue the defective osteoclastogenesis and further support that Rgs12 is crucial for OC differentiation.
Results

Generation
Deletion of Rgs12 impaired OC function. As deletion of Rgs12 causes defective OC differentiation, we further studied the effects of Rgs12 loss on OC function. F-actin ring podosome belt formation is a prerequisite for OC bone resorption. 28, 29 We used rhodamine-phalloidin staining to assess F-actin ring formation in primary OCs induced by M-CSF/RANKL from the bone marrow cells of the control and CD11b;Rgs12 fl/fl mice. About 60% of OCs from the control mice had complete and organized F-actin rings; whereas, only about 40% of OCs from CD11b;Rgs12 fl/fl mice had wellformed F-actin rings (Figures 5a and b, Po0.01). Nearly 60% of the OCs from CD11b;Rgs12 fl/fl mice had the disrupted actin rings or no rings. Moreover, the size of disrupted actin rings appeared smaller than the size of the actin rings in the control group. We further confirmed these results by using an OB-OC co-culture system (Figures 5c and d, Po0.01). This data suggest that Rgs12 has an important role in organizing OC-specific cytoskeleton and regulates OC function and bone resorption. To further investigate OC function, we utilized a dentin bone resorption assay. The OC cultures of CD11b;Rgs12 fl/fl resulted in significantly less resorbed areas on the elephant dentin slides than did the control group (Figures 5e and f). This indicates that deletion of Rgs12 impairs OC-mediated bone resorption. These results confirmed the importance of Rgs12 as a regulator of OC function.
Deletion of Rgs12 inhibited Ca
2+ oscillations and NFAT2 expression, and ectopic expression of NFAT2 rescued defective OC differentiation in CD11b;Rgs12 fl/fl cells. To gain further insight into the mechanism underlying the regulation of Rgs12 in OC differentiation, we investigated the essential transcription factors and marker genes for OC formation and function. Compared with the control cells, Rgs12-deficient OC progenitor cells had significantly lower expression of NFAT2, c-Fos (transcription factors required for OC differentiation) and Cathepsin K (required for bone resorption) at 24 h after RANKL stimulation (Figure 6a ). These results further confirmed that osteoclastogenesis was impaired in the CD11b;Rgs12 fl/fl group. Accumulating studies showed that Rgs proteins have a critical role in regulating Ca 2+ oscillations in various cells, including pancreatic acinar cells and T lymphocytes, [30] [31] [32] [33] and that Ca 2+ oscillations and NFAT2 activation are essential for RANKL-induced OC differentiation. 13 Thus we hypothesized that Rgs12 is a specific regulator of Ca 2+ oscillations in response to RANKL during OC differentiation. To test this hypothesis, we used Fluo4 to monitor the internal Ca 2+ concentration after CD11b; Rgs12 fl/fl and CD11b;Rgs12 fl/+ mouse bone marrow cells were treated with RANKL and M-CSF for 24 h. Ca Figure S2) .
To further understand the role of Rgs12 in the RANKL-Ca 2+ oscillations-NFAT2 signaling pathway, we ectopically expressed ca-NFAT2 in OC precursor cells using a retrovirus-mediated gene transfer system. 13 Successful NFAT2 overexpression was confirmed by using qPCR after transfection (Figure 6c ). Defective OC differentiation resulting from Rgs12 deletion was partially rescued by retroviral ectopic expression of ca-NFAT2 (Figures 6d and e) . Cathepsin K The function of Rgs12 in bone homeostasis X Yuan et al expression, but not c-Fos, was significantly upregulated after introducing ca-NFAT2 into Rgs12-deficient cells (Figure 6f ). These findings support our hypothesis that Rgs12 acts upstream of NFAT2 signaling and has an important role in RANKL-Ca 2+ oscillations-NFAT2 signaling pathway.
Deletion of Rgs12 in OC precursor cells protected against LPS-induced bone loss. We have shown that Rgs12 has an important role in OC differentiation and bone remodeling under physiological conditions. Next we used a LPS-induced bone resorption model in order to determine whether Rgs12 is involved in inflammation-induced bone loss. [34] [35] [36] [37] LPS were injected into the local calvarial region of CD11b;Rgs12 fl/fl and CD11b;Rgs12 fl/+ mice to induce bone destruction. Histological analysis showed that bone erosion was markedly reduced in the CD11b;Rgs12 fl/fl group (Figure 7a ). Quantitative analysis revealed a greater than two-fold decrease of the osteolytic cavities in CD11b; Rgs12 fl/fl group compared with those of the control group (Figure 7b, Po0.001) . TRAP staining revealed that OC numbers in CD11b;Rgs12 fl/fl mice under this pathological condition were significantly lower than those of the control mice (Figures 7c and d, Po0.001) . These results demonstrated that Rgs12 mediates inflammation-induced osteolysis and that loss of Rgs12 protects against LPS-induced bone loss in vivo.
To further determine the role of Rgs12 in LPS-mediated osteoclastogenesis, control and Rgs12-deficient OC precursor cells were cultured in vitro and treated with LPS in the presence of M-CSF. TRAP staining revealed that LPS-induced OC differentiation occurred without sustained RANKL stimulation, and deletion of Rgs12 dramatically inhibited LPS-induced OC formation (Figure 7e Deletion of Rgs12 protected mice against OVX-induced bone loss. As deletion of Rgs12 in mice under physiological conditions caused osteopetrosis, we next evaluated the effect of the loss of Rgs12 on prevention of estrogen deficiencyinduced osteoporosis. To investigate the bone metabolism of adult mice and avoid the confounding factor of growth 
Discussion
Rgs proteins are involved in bone remodeling through their influences on OC and OB differentiation and function. [39] [40] [41] [42] It was previously demonstrated that Rgs12, the largest protein in the Rgs family, is predominantly expressed in OCs and regulates OC differentiation in vitro. To define the role of Rgs12 in vivo, we generated Rgs12 conditional knockout mice. Mx1-Cre targets not only OC precursor cells but also multiple hematopoietic cell types, including megakaryocytes, lymphocytes, mast cells, and monocytemacrophages. To specifically understand the role of Rgs12 in OC lineage in vivo, we also generated a specific conditional knockout model with CD11b-Cre for deleting Rgs12 more exclusively in the OC lineage cells at a relatively early and developmental stage 22 to facilitate understanding of Rgs12 in OC differentiation and function. CD11b;Rgs12 fl/fl and Mx1;Rgs12 fl/fl mice all displayed skeletal defects such as a marked increase in cancellous bone mass and decreased OC numbers. These observations are consistent with impaired OC differentiation and function of the Rgs12 mutant. As expected, isolated bone marrow cells exhibited a striking inability to differentiate into OCs. Additionally, although a few TRAP + OC-like cells were formed in the CD11b;Rgs12 fl/fl group, 60% of these cells had impaired cytoskeleton organization and bone resorption. The function of Rgs12 in bone homeostasis X Yuan et al
Our results further showed that Rgs12-deficient OC lineage cells lacked Ca 2+ oscillations in response to RANKL and therefore reduced NFAT2 expression. In addition to RANKL-[Ca 2+ ] i oscillation-NFATc1 pathway, Rgs12 also regulates c-fos expression; this suggested that Rgs12 may be involved in RANKL-JNK-c-Fos pathway. 43 Overexpression of NFAT2 partially restored the differentiation ability and Cathepsin K expression but not c-Fos expression in Rgs12-deficient OC precursor cells. This is supported by the findings from Takayanagi et al. that NFAT2 cooperates with c-Fos to lead to OC differentiation and that overexpression of NFAT2 can only partially restore the osteoclastogenesis in NFAT2-mutant cells. 13 Therefore, we can explain that reduced expression of c-fos restricted from the full restoration. Thus, our findings indicate that Rgs12 acts in the downstream of RANKL and upstream of NFAT2 and has a critical role in the regulation of RANKL-Ca 2+ oscillations-NFAT2 pathway during OC differentiation and function.
In addition to the role that Rgs12 has in physiological conditions, we found that Rgs12 mediates osteoclastogenesis and bone loss after LPS challenge. Previous studies have indicated that LPS causes bone destruction by inducing interleukin-1 (IL-1), IL-11, prostaglandins, and tumor necrosis factor receptor signaling. 34, 44 These cytokines may be secreted by OBs, fibroblasts, or immune cells upon LPS stimulation and stimulate OC precursor, accelerating osteoclastogenesis. In both models, we found that deletion of Rgs12 inhibits LPS-induced bone loss, suggesting impaired osteoclastogenesis in the CD11b;Rgs12 fl/fl OC precursors protect the mice from cytokine-driven bone loss. In addition to stimulating OBs, fibroblasts, or immune cells, it is also possible that LPS directly triggers Toll-like receptors 2 (TLR2) and TLR4 in pre-OCs or OC precursor cells to promote OC differentiation. 45, 46 Liu et al. 47 reported that LPS has bifunctional roles in osteoclastogenesis in vitro. LPS stimulates NFAT2 expression in RANKL-pretreated cells and therefore promotes osteoclastogenesis. However, LPS abolishes RANKL-induced NFAT2 expression in freshly isolated OC precursors. In our study, the OC precursor cells in bone marrow were pretreated with RANKL for 36 h and then induced with 100 ng/ml LPS for additional 5 days. TRAP staining revealed a significant fewer in OC number in the CD11b;Rgs12 fl/fl group than in the control group, demonstrating that Rgs12 likely regulates LPS-induced osteoclastogenesis through the regulation of NFAT2 expression and activation. Inhibition of Rgs12 might be a promising approach to treating inflammation-induced bone loss diseases.
Estrogen is a female hormone that helps to maintain healthy bones. Women after menopause are at a high risk for osteoporosis due to lower levels of estrogen. 48 The use of OVX animals is common to investigate postmenopausal osteoporosis and to facilitate the development of new treatments for this disease. 49 OVX mouse is a powerful tool for the study of pathogenesis of postmenopausal osteoporosis using various transgenic mice. In OVX-induced aging mice, we found that mice lacking Rgs12 in OC precursors were partially protected from age-associated bone loss. We detected much higher BV/TV, Tb.N, and trabecular spacing, as well as a slight increase in MAR and BFR/BS in Mx1;Rgs12 fl/fl and Mx1; Rgs12 +/+ mice. This could be due to the involvement of Wolff's Law. Wolff's law-induced adaption should result in an increase of OBs and OCs. However, because of markedly inhibited OC differentiation in Mx1;Rgs12 fl/fl mice, relatively increased OBs and decreased OCs cause unbalanced bone formation and resorption, which favors bone formation in Mx1;Rgs12 fl/fl . Most recently, it was reported that Mx1 is also expressed in a subset of mesenchymal stem cells (MSCs). 50 These Mx1 + MSCs are OB lineage-restricted stem/progenitor cells that respond to tissue stress and migrate to sites of injury, supplying new OBs during fracture healing. Thus we cannot rule out the possibility that Rgs12 exerts a slight effect on OB function that results in a measurable change in BFR/BS and MAR. However, our data demonstrated that the OC dysfunction predominated, resulting in an overall increase in BV/TV.
In summary, we demonstrated that Rgs12 has a crucial role in the function of bone-resorbing OCs, particularly in preclinical models of pathological bone loss associated with inflammation-induced bone loss and postmenopausal osteoporosis. Our data suggest that Rgs12 has potential as a novel drug target for preventing postmenopausal osteoporosis and inflammation-induced bone loss. Genotyping of mice was performed by PCR of proteinase K-digested tail or spleen DNA as we have previously done. 25 The Cre transgene was detected using primer CreF (5′-CCTGGAAAATGCTT CTGTCCGTTTGCC-3′) and primer CreB (5′-GGCGCGGCAACACCATTTTT-3′). The deleted, floxed, and wild-type alleles The function of Rgs12 in bone homeostasis X Yuan et al were genotyped using three primers: S (5′-CAGTTATTGGAAACTATCTCATGAC-3′); M (5′-TCCCCAAGCCTCTTACTTCA-3′); and W (5′-CACCGCACACACAAAATAAA TATCA-3′). All experimental mice (CD11b;Rgs12 fl/fl and CD11b;Rgs12 fl/+ ) were male because transgene integration of CD11b-Cre is on the Y chromosome. 22 All animal studies were approved by University at Buffalo Institutional Animal Care and Use Committee.
Isolation of CD11b-positive cells from bone marrow cells. CD11b-positive cells were isolated from the bone marrow cells from CD11b;Rgs12 +/+ and CD11b;Rgs12 fl/+ mice using a CD11b MicroBeads kit (Miltenyi Biotec Inc., Auburn, CA, USA) following the manufacturer's instructions. CD11b-positive cells were subjected to Rgs12 expression analysis by using quantitative real-time PCR (qPCR) and western blotting.
qPCR. Total RNA was isolated from the spleen, cultured OCs or CD11b-positive cells from mouse bone marrow using Trizol reagent (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions. cDNA was synthesized from 2 μg total RNA using the RNA to cDNA EcoDry Premix kit (Clontech, Palo Alto, CA, USA). Primers were designed with the IDT SCI primer design tool (Integrated DNA Technologies, San Diego, CA, USA). qPCR experiments were performed on an ABI PRISM 7500 real-time PCR system (Invitrogen) with SYBR Green PCR master Mix (Invitrogen). Sequences and product lengths for each primer pair were as follows: Rgs12 (Forward: 5′-GTGACCGTTGATGCTTTCG-3′; Reverse: 5′-ATCGCATG TCCCACTATTCC-3′, 132 bp); Cathepsin K (Forward: 5′-GCATTACCAACATGGC CAGC -3'; Reverse: 5′-CTCCCTTCCAAAGCCACCAA-3′; 109 bp); c-Fos (Forward: 5′-CGACCATGATGTTCTCGGGT-3′; Reverse: 5′-TCGGCTGGGGAATGGTAGTA -3′; 109 bp); NFAT2 (Forward: 5′-ATATGAGCCCATCCTTGCCTGCC-3′; Reverse: 5′-TTGGGCTGCACCTCGATCCG-3′, 85 bp); and GAPDH (Forward: 5′-TGTGTC CGTCGTGGATCTGA-3′; Reverse 5′-TTGCTGTTGAAGTCGCAGGAG-3′; 150 bp). All reactions were run in triplicate and normalized to the housekeeping gene GAPDH.
Western blotting. Western blotting was used to detect RGS12 using the chicken anti-Rgs12 antibody (1 : 500, Abcam, Cambridge, MA, USA). For Mx1; Rgs12 fl/fl mice, bone marrow from poly I:C-induced mice were harvested. For CD11b;Rgs12 fl/fl mice, bone marrow cells were purified with CD11b MicroBeads Kit. All samples were homogenized with RIPA buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.1% SDS and 1% sodium deoxycholate) combined with protease inhibitor cocktail (Sigma, St Louis, MO, USA). About 20-40 μg proteins were loaded and separated in 10% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. The membranes were incubated with primary antibody overnight at 4°C and then incubated with horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 h. Visualization was done with WesternBright ECL HRP (Advansta, Menlo Park, CA, USA). GAPDH (1 : 2000, Genscript, Piscataway, NJ, USA) was used as the internal control.
Radiographic procedures and quantitative Micro-CT measurements. Radiography was performed by using Siemens X-ray equipment (Siemens, Madison, WI, USA) with high-speed holographic film (Kodak, Rochester, NY, USA). A quantitative analysis of the gross bone morphology and microarchitecture was performed by a Micro-CT system (USDA Grand Forks Human Nutrition Research Center, Grand Forks, ND, USA). Fixed femur from Rgs12 mutant and Cre control mice (n = 4) were analyzed and 3D reconstitution was used to determine bone volume (BV/TV), trabecular number (Tb.N), and trabecular thickness (Tb.Th) as described. 25, 51, 52 Histology and histomorphometric analyses. Mice femurs and tibias were excised, fixed for 24 h in 10% natural buffered formalin, and decalcified in 10% EDTA for 1-2 weeks at 4°C. The samples were embedded in paraffin and then sectioned at 5 μm and stained with H&E (n = 4).
TRAP staining was performed after deparaffinization using an acid phosphatase, leukocyte (TRAP) Kit (Sigma). OC number per bone surface (N.Oc/B.S, n/mm 2 ) and the percentage of OC surface to bone surface (Oc.S/B.S, %) were calculated by counting TRAP + cells and measuring the area in sagittal histological sections of the tibia (normalized to the total bone surface) using the Image J software (US National Institutes of Health, Bethesda, MA, USA) (n = 4).
In vitro osteoclastogenesis and retroviral gene transfer. Nonadherent bone marrow cells were obtained from the tibia and femur bone marrow cavity of CD11b;Rgs12 fl/fl and CD11b;Rgs12 +/+ mice as described. 21 26, 54 For rescue experiments, ca-NFAT2 retrovirus was generated with ca-NFAT2 vector (Addgene plasmid 11102, Cambridge, MA, USA) and phoenix Eco packaging cells (Garry Nolan, Stanford University, Stanford, CA, USA) as previously described. 55 Nonadherent bone marrow cells were cultured with M-CSF for another 24 h and incubated with viral supernatant for 8 h in the presence of 8 μg/ml polybrene. 40, 56, 57 After removing the viral-containing medium, the cells were cultured with 20 ng/ml M-CSF and 10 ng/ml RANKL for 3-4 days. OCs were stained with TRAP and analyzed by using qPCR.
TRAP staining was performed at the end with the acid phosphatase, using leukocyte (TRAP) Kit (Sigma). The osteoclastogenesis level was determined by counting the number of TRAP + multinucleated cells (MNCs, 43 nuclei/cell) per well under × 20 magnification. The experiments were carried out in quadruplicate.
Fluorescent staining for actin ring of OCs. OCs generated from RANKL induction or co-culture were fixed with 3.7% formaldehyde solution in PBS for 10 min at room temperature and permeabilized with ice-cold acetone at − 20°C for 5 min. OC actin rings were stained with rhodamine-phalloidin (Sigma, R415) (1 : 40 dilution) following the manufacturer's instructions. After staining, 4,6-diamidino-2-phenylindole (DAPI) (Sigma) was added and used as a counterstain for nuclei. Actin rings were analyzed by using Zeiss Axio imager microscope (Carl Zeiss, Jena, Germany). The calculation of the normal actin rings and disrupted actin rings were performed as described. 29, 58 Briefly, an actin ring with less than half a ring was counted as the disrupted ring, and OCs were identified by the presence of more than two nuclei. The experiments were repeated independently three times.
Dentin resorption assay. Dentin resorption assay was performed as previously described with minor modifications. 21, 59 Briefly, bone marrow cells were plated on the transverse slices of elephant dentin (Elephant Ivory Tusks, FL, USA) in 24-well plate and induced with α-MEM containing 10% FBS (pH 6.9), 20 ng/ml M-CSF, and 10 ng/ml RANKL. After 6 days in culture, OCs were removed by sonication, and the resorbed area was measured using Hitachi SU70 scanning electron microscope (Hitachi Instruments, Schaumburg, IL, USA) (n = 3).
Ca
2+ oscillation measurement. Ca 2+ oscillation measurements were performed as previously described with minor modification. 13, 21 Nonadherent bone marrow cells from CD11b;Rgs12 fl/+ and CD11b;Rgs12 fl/fl mice were induced with 20 ng/ml M-CSF and 10 ng/ml RANKL for 24 h. The cells were loaded with 5 μM fluo-4 AM (Invitrogen) for 30 min in α-MEM containing 0.05% pluronic F127 (Sigma) and washed in Hank's Balanced Salt Solution. Intracellular Ca 2+ concentration change was accessed by using a Zeiss Axio imager Motorized fluorescence microscope. The cells were excited at 488 nm, and the emission signals for 505-530 nm were recorded simultaneously at 5-s intervals for 5 min. The fluorescence intensity was calculated using the Image J software and plotted over time (n = 5).
LPS-induced osteogenesis and bone erosion. CD11b;Rgs12 fl/+ and CD11b;Rgs12 fl/fl mice (7-8 weeks old, n = 8) were administered a local calvarial injection of LPS (Sigma, 02:B6, L8274) or PBS (sham group) at 25 mg per kg body weight.
34-37 A 27.5-gauge needle was used, and the injection site was at the point on the midline of the skull located between the ears and eyes. Five days after the initial injection, the mice were euthanized, and histological sections of the calvarial bones were prepared as described above. The levels of osteogenesis and bone loss were assessed by H&E and TRAP staining. Bone resorption was calculated by measuring the ratio of eroded surface over total bone surface. The OC number per bone surface 29 was calculated as described above. LPS-induced in vitro osteoclastogenesis was performed as previously reported. 47 Bone marrow cells from CD11b;Rgs12 fl/+ and CD11b;Rgs12 fl/fl mice were cultured with α-MEM containing 10% FBS, 20 ng/ml M-CSF, and 10 ng/ml RANKL for 36 h and then cultured with α-MEM containing 10% FBS, 20 ng/ml M-CSF, and 100 ng/ml LPS for 5 days. TRAP staining was performed to evaluate OC formation (n = 3).
Ovariectomy. Either ovariectomy or a sham operation was performed in 4-month-old Mx1;Rgs12 +/+ and Mx1;Rgs12 fl/fl females (n = 5 for each group) as reported previously. 60, 61 Three-month-old mice were anesthetized with 1000 cc/min O 2 and 5% isofluorane. Ovaries were approached by two separate flank incisions. The ovary and the oviduct were exteriorized and removed with single cut. The ligated uterine horn was replaced into the peritoneal cavity. The muscle and skin were sutured. In the sham group, ovaries were only touched with forceps. The mice were killed 6 weeks after OVX. One femur was excised for Micro-CT examination.
Statistical analysis. All data are expressed as mean ± S.D. (n = ≥ 3). Student's t-test for the comparison between two groups or one-way ANOVA followed by Tukey's multiple-comparison posttest for multiple groups was performed. Po0.05 was considered to be significant.
